Drug intelligence / Profile preview

salmeterol + fluticasone propionate

Development stage: Unknown
Lead developer: Korea United Pharm
Modality: Small Molecules
Administration: Inhalation

Overview

UIC202005 is a dry powder inhaler (DPI) combination therapy developed by Korea United Pharm, containing the long-acting beta2-adrenergic agonist (LABA) salmeterol xinafoate and the inhaled corticosteroid (ICS) fluticasone propionate. It is being developed as an improved formulation of the company's existing product UI009 (Combi-Air), which is a generic version of the reference drug Seretide (Advair). Salmeterol provides prolonged bronchodilation by relaxing airway smooth muscle through beta2-receptor activation, while fluticasone propionate exerts potent anti-inflammatory effects by binding to glucocorticoid receptors. The combination is intended for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), aiming to improve lung function and reduce the frequency of exacerbations.

Other names: salmeterol xinafoate + fluticasone propionate

Targets

GR (Glucocorticoid receptor)ADRB2 (β2)

Beyond the preview

Go deeper on salmeterol + fluticasone propionate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on salmeterol + fluticasone propionate.

Explore the full profile